US panel votes in favour of Xillix' LIFE-lung
This article was originally published in Clinica
Executive Summary
An FDA advisory panel voted on June 11th to recommend approval of Xillix' LIFE-Lung system for use in patients with known and suspected lung cancer for the identification of suspicious tissue. Members of the ear, nose and throat device panel recommended that final approval be conditional on labelling changes and initiation of a post-market surveillance study.